Company / Working Capital per Share
RIGEL PHARMACEUTICALS INC Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$7.96
FY2025
5-year range
$0.27 / $7.96
FY2021-FY2025
Trend
+93.7%
vs FY2024
Sector context
#64 of 210
Health Care
What the data says
At $7.96, RIGEL PHARMACEUTICALS INC's working capital per share ranks #64 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $0.27 in FY2023 to $7.96 in FY2025.
Based on SEC 10-K filings.
7.96 in FY2025 with a 5-year CAGR of +94.4%.
Improved from $0.27 to $7.96 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +199.8%
- 5-Year CAGR
- +94.4%
- 10-Year CAGR
- -
Sector benchmark
#64 of 210 in Health CareTop 30% of 210This company $7.96 Sector average $118.60
▼
-93.3% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 93.7% year-over-year.
- Ranks #64 out of 210 companies in the Health Care sector.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.96 | +93.7% |
| FY2024 | $4.11 | +1448.3% |
| FY2023 | $0.27 | -10.2% |
| FY2022 | $0.30 | -45.0% |
| FY2021 | $0.54 | +87.4% |
| FY2020 | $0.29 | -21.2% |
| FY2019 | $0.36 | -51.1% |
| FY2018 | $0.74 | -5.1% |
| FY2017 | $0.78 | +38.1% |
| FY2016 | $0.57 | -47.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026